Skip to Content
Merck
CN

An Update on Randomized Clinical Trials in Breast Cancer.

Surgical oncology clinics of North America (2017-09-20)
Kayla Barnard, V Suzanne Klimberg
ABSTRACT

Numerous clinical trials reveal new innovations and therapies that continually change the treatment and prevention of breast cancer. Earlier trials have changed the standard of care from radical mastectomy to breast conservation therapy and individualized treatment based on tumor-specific biology. As research continues and long-term follow-up results become available, updated reviews on randomized clinics trials become exceedingly important in discerning the most effective and oncologically safe therapies to provide optimal outcomes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lapatinib